The use of combination Phacoemulsification, OMNI Canaloplasty and Hydrus microstent successfully lowers IOP in ethnically-diverse patients with Open Angle Glaucoma
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subjects with h/o CEIOL/OMNI/Hydrus (chosen based on subjects on more than 1 medication pre-operatively) with at least 3 years of follow up data
have Glaucoma
You may not be if
Patients with angle closure glaucoma or secondary forms of glaucoma due to neovascularization of the angle, uveitic glaucoma, congenital glaucoma, or glaucoma due to congenital anomalies.
Patients with refractory CME or CME persisting 3 months or more post-operatively
Patients with incomplete IOP, medication logs or VF data within post-operative period
Prior incisional surgery or MIGS
Clareo Health | Efficacy of Surgical Systems in Combination With Phacoemulsification: a Retrospective Analysis
